The American Society for Radiation Oncology (ASTRO) has released evidence-based guidelines supporting the use of hypofractionated (HF) whole breast irradiation (WBI) for certain patients with early-stage breast cancer, based on the findings of a study published in the August edition of the International Journal of Radiation, Oncology, Biology and Physics.

Elekta has received the CE mark for its digital imaging system, iView, for use with Elekta Compact, its linear accelerator for radiation therapy.

Breast cancer device developer Orbital Therapy has received a U.S. patent for a self-shielded radiotherapy device, which does not require a traditional vault for operation.

The FDA issued two evaluations containing recommendations that address three objectives of the agencys public health mission as it relates to medical devices--foster device innovation, create a more predictable regulatory environment and enhance device safety.

The FDA has cleared VeraLook, iCADs computer-aided detection product, used in the interpretation of virtual colonoscopy exams.

Medrad, a subsidiary of Bayer HealthCare, has signed a distribution agreement with Avondale, Pa.-based radiation therapy provider WFR-AquaPlast/Qfix Systems, for the companys Pro-Tekt endorectal balloon device.

Auckland Radiation Oncology Centre in Auckland, New Zealand, has installed radiotherapy technology from Elekta, the Elekta VMAT system.

The Centers for Medicare & Medicaid Services (CMS) has issued a prospective payment system final rule for fiscal year 2011 for acute-care and long-term care hospitals that would decrease average inpatient payments by 0.4 percent.